Duration an interview that was issued in the Friday transmission of “The Claman Countdown” by FBN, the CEO of Amgen, Robert Bradway, announced his company’s decision to invest $ 1 billion in his installation of Columbus, OH,.
“How many jobs, permanent versus construction, will this part add?” Fox Business Network presenter Liz Claman, asked.
“Well, we are adding about one billion dollars of investment today, and we hope to permanently hire another hundreds of personnel as a result of this expansion,” Bradway replied. “Then, we will have around one billion and a half invested in Columbus and around 750 people who work in our biography there.”
According to Bradway, the measure is part of a tendency to return manufacturing to the United States, due in part to Trump administration policies.
“In the 2018-2024 period, we invest around $ 5 billion in manufacturing in the United States, which gave rise to approximately $ 12 billion in incremental economic activity,” explains the pharmaceutical executive.
Bradway also promoted Trump’s tax cuts in 2017 as a launching point for Amgen’s infrastructure base in the United States.
“Our manufacturing base originated in the United States,” he said. “And so, most of our manufacture in our business begged in the United States. Fiscal reform in 2017 allowed us to invest incremental in the United States. Therefore, we have continued to increase our manufacturing base here.”
Follow Jeff Poor at x @jeff_poor
